机器学习识别口腔癌放疗后CT肌肉丢失的生存阈值
本研究纳入两个中心1087例接受手术和辅助放疗的口腔鳞癌患者,利用放疗前后C3椎体水平CT测量的骨骼肌指数,开发随机森林、XGBoost和CatBoost模型预测全因死亡,并用SHAP方法识别肌肉丢失阈值。外部验证中模型AUC达0.842-0.898,SHAP一致识别SMI丢失≥4.2%为阈值,多变量分析显示该阈值与全因死亡风险独立相关(推导队列HR 6.66,外部验证HR 8.46,均p<0.001)。
要点
- 放疗后C3水平CT测量的骨骼肌指数丢失≥4.2%提示全因死亡风险显著增加。
- 该阈值在两个独立队列中均经Cox回归验证,可作为报告中的风险分层指标。
- SHAP分析显示放疗后SMI变化是预测全因死亡的最重要特征。
局限性
- 回顾性研究设计。
- 原文未报告其他明显局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Muscle loss after radiotherapy is associated with poorer survival in patients with oral cavity squamous cell carcinoma (OCSCC). However, the threshold of muscle loss remains unclear. This study aimed to utilize explainable artificial intelligence to identify the threshold of muscle loss associated with survival in OCSCC.
MATERIALS AND METHODS: We enrolled 1087 patients with OCSCC treated with surgery and adjuvant radiotherapy at two tertiary centers (660 in the derivation cohort and 427 in the external validation cohort). Skeletal muscle index (SMI) was measured using pre- and post-radiotherapy computed tomography (CT) at the C3 vertebral level. Random forest (RF), eXtreme Gradient Boosting (XGBoost), and Categorical Boosting (CatBoost) models were developed to predict all-cause mortality, and their performances were evaluated using the area under the curve (AUC). Muscle loss threshold was identified using the SHapley Additive exPlanations (SHAP) method and validated using Cox regression analysis.
RESULTS: In the external validation cohort, the RF, XGBoost, and CatBoost models achieved favorable performance in predicting all-cause mortality (AUC: 0.898, 0.859, and 0.842). The SHAP method demonstrated that SMI change after radiotherapy was the most important feature for predicting all-cause mortality and consistently identified SMI loss ≥ 4.2% as the threshold in all three models. In multivariable analysis, SMI loss ≥ 4.2% was independently associated with increased all-cause mortality risk in both cohorts (derivation cohort: hazard ratio: 6.66, p < 0.001; external validation cohort: hazard ratio: 8.46, p < 0.001).
CONCLUSION: This study can assist clinicians in identifying patients with considerable muscle loss after treatment and guide interventions to improve muscle mass.
KEY POINTS: Question Muscle loss after radiotherapy is associated with poorer survival in patients with oral cavity cancer; however, the threshold of muscle loss remains unclear. Findings Explainable artificial intelligence identified muscle loss ≥ 4.2% as the threshold of increased all-cause mortality risk in both derivation and external validation cohorts. Clinical Relevance Muscle loss ≥ 4.2% may be the optimal threshold for survival in patients who receive adjuvant radiotherapy for oral cavity cancer. This threshold can guide clinicians in improving muscle mass after radiotherapy.
引用
- Lee J, Lin JB, Lin WC, et al. Identifying threshold of CT-defined muscle loss after radiotherapy for survival in oral cavity cancer using machine learning. Eur Radiol. 2024. PMID: 39706923. doi:10.1007/s00330-024-11303-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。